The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Figure 19.1

CSR Figure 19.1: SEER Incidence, Delay Adjusted Incidence and US Death Rates by Race and Sex


Figure 19.1

Rates per 100,000 for Non-Hodgkin Lymphoma, White, Male, 1975-2015, All Ages

Year Delay-Adjusted SEER IncidenceDelay-Adjusted SEER Incidence
Modeled (from Joinpoint)
Observed SEER IncidenceObserved SEER Incidence
Modeled (from Joinpoint)
U.S. MortalityU.S. Mortality
Modeled (from Joinpoint)
1975 13.5 12.7 13.5 12.7 7.2 6.9
1976 13.3 13.2 13.3 13.2 7.1 7.1
1977 13.5 13.8 13.5 13.8 7.1 7.2
1978 14.7 14.4 14.7 14.4 7.5 7.4
1979 14.6 15.1 14.6 15.1 7.7 7.6
1980 15.3 15.7 15.3 15.7 7.7 7.8
1981 16.3 16.4 16.3 16.4 7.7 8.0
1982 16.4 17.1 16.4 17.1 8.3 8.3
1983 17.5 17.9 17.5 17.9 8.4 8.5
1984 19.1 18.7 19.1 18.7 8.5 8.7
1985 19.3 19.5 19.3 19.5 9.2 8.9
1986 20.6 20.4 20.6 20.4 9.3 9.2
1987 22.1 21.3 22.1 21.3 9.1 9.4
1988 22.5 22.2 22.5 22.2 9.6 9.7
1989 23.0 23.2 23.0 23.2 10.0 9.9
1990 24.0 24.2 24.0 24.2 10.3 10.2
1991 24.8 24.4 24.8 24.4 10.5 10.4
1992 23.9 24.5 23.9 24.5 10.7 10.6
1993 24.3 24.7 24.3 24.7 10.5 10.8
1994 25.6 24.8 25.6 24.8 11.2 11.0
1995 26.2 25.0 26.2 25.0 11.2 11.1
1996 25.2 25.1 25.2 25.1 11.3 11.3
1997 25.2 25.3 25.2 25.3 11.4 11.5
1998 24.0 25.4 24.0 25.4 11.3 11.2
1999 25.5 25.6 25.5 25.6 10.7 10.9
2000 25.7 25.7 25.7 25.7 10.6 10.6
2001 25.5 25.9 25.5 25.9 10.3 10.3
2002 25.5 26.0 25.5 26.0 10.0 10.0
2003 26.3 26.2 26.3 26.2 9.8 9.7
2004 26.9 26.4 26.9 26.4 9.3 9.4
2005 26.7 26.5 26.7 26.5 9.2 9.2
2006 26.1 26.7 26.1 26.7 8.8 8.9
2007 27.6 26.8 27.6 26.8 8.7 8.7
2008 26.9 27.0 26.8 27.0 8.6 8.5
2009 26.7 26.8 26.6 26.7 8.4 8.4
2010 27.6 26.6 27.4 26.5 8.1 8.2
2011 25.6 26.5 25.4 26.2 8.2 8.0
2012 26.2 26.3 25.9 26.0 7.9 7.9
2013 25.6 26.1 25.3 25.7 7.7 7.7
2014 26.5 26.0 26.1 25.5 7.6 7.6
2015 26.5 25.8 26.0 25.3 7.4 7.4
2016 25.0 25.6 24.3 25.0 7.2 7.3

Rates per 100,000 for Non-Hodgkin Lymphoma, Black, Male, 1975-2015, All Ages

Year Delay-Adjusted SEER IncidenceDelay-Adjusted SEER Incidence
Modeled (from Joinpoint)
Observed SEER IncidenceObserved SEER Incidence
Modeled (from Joinpoint)
U.S. MortalityU.S. Mortality
Modeled (from Joinpoint)
1975 7.3 7.5 7.3 7.5 4.8 4.6
1976 7.4 7.9 7.4 7.9 4.5 4.7
1977 7.2 8.3 7.2 8.3 4.9 4.8
1978 9.5 8.8 9.5 8.8 5.4 5.0
1979 12.0 9.3 12.0 9.3 4.5 5.1
1980 10.7 9.8 10.7 9.8 5.1 5.2
1981 10.6 10.3 10.6 10.3 5.0 5.4
1982 10.2 10.9 10.2 10.9 5.2 5.5
1983 10.9 11.5 10.9 11.5 5.8 5.6
1984 12.5 12.1 12.5 12.1 5.3 5.8
1985 12.0 12.8 12.0 12.8 5.6 5.9
1986 13.1 13.5 13.1 13.5 6.6 6.1
1987 10.4 14.2 10.4 14.2 6.3 6.3
1988 15.8 15.0 15.8 15.0 6.8 6.4
1989 14.1 15.8 14.1 15.8 7.1 6.6
1990 17.6 16.6 17.6 16.7 7.1 6.8
1991 18.8 17.5 18.8 17.6 7.2 7.0
1992 18.9 18.5 18.9 18.6 7.2 7.1
1993 19.4 19.5 19.4 19.6 7.5 7.3
1994 21.5 20.6 21.5 20.7 6.8 7.5
1995 23.6 20.5 23.6 20.6 7.6 7.7
1996 19.2 20.5 19.2 20.5 8.2 7.9
1997 24.3 20.4 24.3 20.5 8.4 7.7
1998 17.0 20.4 17.0 20.4 7.5 7.6
1999 18.4 20.3 18.4 20.3 7.4 7.4
2000 18.2 20.3 18.2 20.2 6.6 7.2
2001 18.4 20.2 18.4 20.2 7.3 7.0
2002 17.1 20.2 17.1 20.1 6.9 6.9
2003 20.1 20.1 20.1 20.0 5.8 6.7
2004 24.2 20.1 24.2 20.0 6.2 6.5
2005 20.0 20.0 20.0 19.9 6.1 6.4
2006 21.0 20.0 21.0 19.8 6.3 6.2
2007 19.3 19.9 19.3 19.7 5.8 6.1
2008 19.0 19.9 18.9 19.7 5.5 5.9
2009 18.7 19.8 18.6 19.6 6.1 5.8
2010 23.4 19.8 23.2 19.5 5.8 5.7
2011 17.7 19.7 17.5 19.5 5.7 5.5
2012 19.3 19.7 19.0 19.4 5.4 5.4
2013 18.4 19.7 18.1 19.3 5.3 5.3
2014 20.4 19.6 20.0 19.3 5.3 5.1
2015 20.0 19.6 19.5 19.2 5.2 5.0
2016 19.8 19.5 19.1 19.1 4.8 4.9

Rates per 100,000 for Non-Hodgkin Lymphoma, White, Female, 1975-2015, All Ages

Year Delay-Adjusted SEER IncidenceDelay-Adjusted SEER Incidence
Modeled (from Joinpoint)
Observed SEER IncidenceObserved SEER Incidence
Modeled (from Joinpoint)
U.S. MortalityU.S. Mortality
Modeled (from Joinpoint)
1975 10.1 10.0 10.1 10.0 4.8 4.9
1976 10.5 10.3 10.5 10.3 5.0 5.0
1977 10.2 10.6 10.2 10.6 5.1 5.1
1978 10.7 10.9 10.7 10.9 5.1 5.2
1979 11.8 11.3 11.8 11.3 5.1 5.3
1980 11.2 11.6 11.2 11.6 5.5 5.4
1981 12.4 12.0 12.4 12.0 5.5 5.6
1982 12.1 12.3 12.1 12.3 5.7 5.7
1983 12.4 12.7 12.4 12.7 5.8 5.8
1984 13.5 13.1 13.5 13.1 6.0 5.9
1985 13.8 13.5 13.8 13.5 6.0 6.0
1986 13.7 13.9 13.7 13.9 6.3 6.2
1987 14.0 14.3 14.0 14.3 6.4 6.3
1988 14.9 14.8 14.9 14.8 6.5 6.4
1989 14.5 15.0 14.5 15.0 6.7 6.6
1990 15.5 15.2 15.5 15.2 6.6 6.7
1991 15.3 15.4 15.3 15.4 7.0 6.9
1992 15.8 15.7 15.8 15.6 7.0 7.0
1993 15.7 15.9 15.7 15.9 7.2 7.1
1994 16.5 16.1 16.5 16.1 7.4 7.3
1995 16.0 16.3 16.0 16.3 7.5 7.5
1996 16.2 16.6 16.2 16.6 7.5 7.6
1997 17.5 16.8 17.5 16.8 7.6 7.8
1998 17.8 17.0 17.8 17.1 7.4 7.5
1999 17.3 17.3 17.3 17.3 7.2 7.2
2000 17.1 17.5 17.1 17.6 7.0 6.9
2001 17.1 17.8 17.1 17.8 6.7 6.7
2002 18.0 18.0 18.0 18.1 6.4 6.4
2003 18.5 18.3 18.5 18.3 6.1 6.2
2004 18.9 18.6 18.9 18.6 6.0 5.9
2005 18.2 18.4 18.2 18.4 5.8 5.8
2006 18.4 18.3 18.4 18.3 5.7 5.6
2007 18.4 18.2 18.4 18.2 5.5 5.5
2008 17.7 18.1 17.6 18.0 5.3 5.3
2009 18.1 18.0 18.1 17.9 5.1 5.2
2010 18.3 17.9 18.2 17.7 5.0 5.0
2011 17.2 17.8 17.0 17.6 4.8 4.9
2012 17.6 17.7 17.4 17.4 4.8 4.8
2013 17.2 17.6 17.0 17.3 4.6 4.7
2014 17.8 17.4 17.5 17.2 4.6 4.5
2015 17.5 17.3 17.2 17.0 4.3 4.4
2016 17.3 17.2 16.8 16.9 4.4 4.3

Rates per 100,000 for Non-Hodgkin Lymphoma, Black, Female, 1975-2015, All Ages

Year Delay-Adjusted SEER IncidenceDelay-Adjusted SEER Incidence
Modeled (from Joinpoint)
Observed SEER IncidenceObserved SEER Incidence
Modeled (from Joinpoint)
U.S. MortalityU.S. Mortality
Modeled (from Joinpoint)
1975 5.3 6.1 5.3 6.1 2.9 2.8
1976 5.0 6.3 5.0 6.3 2.8 2.8
1977 6.1 6.5 6.1 6.5 3.1 2.9
1978 5.2 6.7 5.2 6.7 2.8 3.0
1979 5.9 6.9 5.9 6.9 3.0 3.1
1980 7.2 7.1 7.2 7.1 3.1 3.1
1981 5.0 7.3 5.0 7.3 3.3 3.2
1982 10.0 7.5 10.0 7.5 3.3 3.3
1983 9.6 7.7 9.6 7.7 3.2 3.4
1984 6.9 7.9 6.9 7.9 3.4 3.5
1985 8.4 8.2 8.4 8.2 3.9 3.6
1986 8.5 8.4 8.5 8.4 3.7 3.7
1987 9.9 8.6 9.9 8.6 3.6 3.8
1988 8.5 8.9 8.5 8.9 3.7 3.9
1989 9.7 9.1 9.7 9.1 4.1 4.0
1990 11.0 9.4 11.0 9.4 4.2 4.1
1991 10.3 9.7 10.3 9.7 4.6 4.2
1992 9.6 10.0 9.6 10.0 4.5 4.3
1993 10.0 10.3 10.0 10.3 4.4 4.5
1994 8.9 10.5 8.9 10.6 4.6 4.6
1995 11.4 10.9 11.4 10.9 4.5 4.7
1996 12.4 11.2 12.4 11.2 4.7 4.8
1997 10.9 11.5 10.9 11.5 4.9 4.7
1998 12.5 11.8 12.5 11.8 4.9 4.6
1999 11.4 12.2 11.4 12.2 4.4 4.5
2000 10.7 12.5 10.7 12.6 4.2 4.4
2001 13.9 12.9 13.9 12.9 4.5 4.3
2002 12.5 13.3 12.5 13.3 4.4 4.2
2003 13.8 13.6 13.8 13.7 4.3 4.1
2004 14.5 14.0 14.5 14.1 4.1 4.1
2005 14.1 14.0 14.1 14.0 3.8 4.0
2006 12.9 13.9 12.9 13.8 3.9 3.9
2007 13.2 13.8 13.2 13.7 3.6 3.8
2008 15.1 13.7 15.0 13.6 3.5 3.7
2009 13.0 13.6 12.9 13.5 3.4 3.6
2010 13.3 13.5 13.2 13.4 3.6 3.6
2011 12.5 13.4 12.4 13.2 3.4 3.5
2012 14.6 13.3 14.4 13.1 3.5 3.4
2013 13.9 13.3 13.7 13.0 3.3 3.3
2014 11.5 13.2 11.3 12.9 3.4 3.3
2015 12.1 13.1 11.7 12.8 3.2 3.2
2016 14.3 13.0 13.8 12.7 3.1 3.1

Annual Percent Changes for the most recent trend in the data series as calculated by Joinpoint
Non-Hodgkin Lymphoma, All Ages, 1975-2015

Data Series Year Range for APC APC
Delay-Adjusted SEER Incidence, White, Male2008-16-0.7
Observed SEER Incidence, White, Male2008-16-0.9*
U.S. Mortality, White, Male2006-16-2.0*
Delay-Adjusted SEER Incidence, Black, Male1994-16-0.2
Observed SEER Incidence, Black, Male1994-16-0.4
U.S. Mortality, Black, Male1996-16-2.4*
Delay-Adjusted SEER Incidence, White, Female2004-16-0.6*
Observed SEER Incidence, White, Female2004-16-0.8*
U.S. Mortality, White, Female2004-16-2.7*
Delay-Adjusted SEER Incidence, Black, Female2004-16-0.6
Observed SEER Incidence, Black, Female2004-16-0.9
U.S. Mortality, Black, Female1996-16-2.2*

Footnotes:

a Source: SEER 9 areas and US Mortality Files (National Center for Health Statistics, CDC). Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103).

Regression lines and APCs are calculated using the Joinpoint Regression Program Version 4.7, February 2019, National Cancer Institute.

The APC is the Annual Percent Change for the regression line segments.

* The APC is significantly different from zero (p < 0.05).

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.